Self-expanding interwoven nitinol stent in severe femoropopliteal arterial disease. Real life results of the Supera Peripheral Stent System^®

References

• Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67.
   PubMed Web of Science ®Google Scholar
• Tendera M, Aboyans V, Bartelink ML, et al. ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the task force on the diagnosis and treatment of peripheral artery diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(22):2851–2906.
   PubMed Web of Science ®Google Scholar
• Jaff MR, White CJ, Hiatt WR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-Knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). Vasc Med. 2015;20(5):465–478.
   PubMed Web of Science ®Google Scholar
• Armstrong EJ, Jeon-Slaughter H, Kahlon RS, et al. Comparative outcomes of supera interwoven nitinol vs bare nitinol stents for the treatment of femoropopliteal disease: insights from the XLPAD registry. J Endovasc Ther. 2020;27(1):60–65.
   PubMed Web of Science ®Google Scholar
• León LR, Jr, Dieter RS, Gadd CL, et al. Preliminary results of the initial United States experience with the supera woven nitinol stent in the popliteal artery. J Vasc Surg. 2013;57(4):1014–1022.
   PubMed Web of Science ®Google Scholar
• Dake MD, Ansel GM, Jaff MR, et al. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol. 2013;61(24):2417–2427.
   PubMed Web of Science ®Google Scholar
• Stoeckel D, Pelton A, Duerig T. Self-expanding nitinol stents: material and design considerations. Eur Radiol. 2004;14(2):292–301.
   PubMed Web of Science ®Google Scholar
• Myint M, Schouten O, Bourke V, et al. A real-world experience with the supera interwoven nitinol stent in femoropopliteal arteries: midterm patency results and failure analysis. J Endovasc Ther. 2016;23(3):433–441.
   PubMed Web of Science ®Google Scholar
• Soga Y, Iida O, Hirano K, et al. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expendable nitinol stent. J Vasc Surg. 2010;52(3):608–615.
   PubMed Web of Science ®Google Scholar
• Montero-Baker M, Ziomek GJ, Leon L, et al. Analysis of endovascular therapy for femoropopliteal disease with the supera stent. J Vasc Surg. 2016;64(4):1002–1008.
   PubMed Web of Science ®Google Scholar
• Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212–E220.
   PubMed Web of Science ®Google Scholar
• Bishu K, Armstrong EJ. Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence. Vasc Health Risk Manag. 2015;11:387–395.
   PubMed Web of Science ®Google Scholar
• Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45(2):312–315.
   PubMed Web of Science ®Google Scholar
• Garcia L, Jaff MR, Metzger C, et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: twelve-month results of the SUPERB trial. Circ Cardiovasc Interv. 2015;8(5):e000937. Erratum in: Circ Cardiovasc Interv. 2015;8(6):e000014.
   PubMed Web of Science ®Google Scholar
• Werner M, Paetzold A, Banning-Eichenseer U, et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–868.
   PubMed Web of Science ®Google Scholar
• Nasr B, Gouailler F, Marret O, et al. Treatment of long femoropopliteal lesions with self-expanding interwoven nitinol stent: 24 month outcomes of the STELLA-SUPERA trial. J Endovascular Therapy. February 2022. doi:10.1177/15266028221075227
   Google Scholar
• Maleckis K, Deegan P, Poulson W, et al. Comparison of femoropopliteal artery stents under axial and radial compression, axial tension, bending, and torsion deformations. J Mech Behav Biomed Mater. 2017;75:160–168.
   PubMed Web of Science ®Google Scholar
• Maleckis K, Anttila E, Aylward P, et al. Nitinol stents in the femoropopliteal artery: a mechanical perspective on material, design, and performance. Ann Biomed Eng. 2018;46(5):684–704.
   PubMed Web of Science ®Google Scholar
• Goltz JP, Ritter CO, Kellersmann R, et al. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther. 2012;19(3):450–456.
   PubMed Web of Science ®Google Scholar
• MacTaggart J, Poulson W, Seas A, et al. Stent design affects femoropopliteal artery deformation. Ann Surg. 2019;270(1):180–187.
   PubMed Web of Science ®Google Scholar